UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Issues for DSM-5: Whither Melancholia? The Case for Its Classification as a Distinct Mood Disorder

The American journal of psychiatry, 2010-07, Vol.167 (7), p.745-747

2010

Volltextzugriff (PDF)

Whither Research Domain Criteria (RDoC)?: The Good, the Bad, and the Ugly

JAMA psychiatry (Chicago, Ill.), 2015-12, Vol.72 (12), p.1161

2015

Volltextzugriff (PDF)

Lifelong opioidergic vulnerability through early life separation: A recent extension of the false suffocation alarm theory of panic disorder

Neuroscience and biobehavioral reviews, 2014-10, Vol.46, p.345-351

2014

Volltextzugriff (PDF)

Difficulties in panic studies

Revista brasileira de psiquiatria, 2013-07, Vol.35 (3), p.215-216

Klein, Donald F

2013

Volltextzugriff (PDF)

Paul Wender

Neuropsychopharmacology (New York, N.Y.), 2016-12, Vol.41 (13), p.3128-3128

Klein, Donald F

2016

Volltextzugriff (PDF)

Industry withdrawal from psychiatric medication development

Revista brasileira de psiquiatria, 2014-09, Vol.36 (3), p.259-261

2014

Volltextzugriff (PDF)

The loss of serendipity in psychopharmacology

JAMA : the journal of the American Medical Association, 2008-03, Vol.299 (9), p.1063

Klein, Donald F

2008

Volltextzugriff (PDF)

Panic, suffocation false alarms, separation anxiety and endogenous opioids

Progress in neuro-psychopharmacology & biological psychiatry, 2008-04, Vol.32 (3), p.603-612

2008

Volltextzugriff (PDF)

Improving detection of adverse effects of marketed drugs

JAMA : the journal of the American Medical Association, 2007-07, Vol.298 (3), p.333

2007

Volltextzugriff (PDF)

The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children

Neuropsychopharmacology (New York, N.Y.), 2006-04, Vol.31 (4), p.689-699

KLEIN, Donald F

2006

Volltextzugriff (PDF)

Monoamine Oxidase Inhibitors: A Clinical Colloquy

Psychiatric annals, 2014-12, Vol.44 (12), p.577-588

2014

Volltextzugriff (PDF)

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision

The world journal of biological psychiatry, 2008, Vol.9 (4), p.248-312

2008

Volltextzugriff (PDF)

Intensive Design to Reinvigorate Psychiatric Drug Development

Journal of clinical psychopharmacology, 2015-12, Vol.35 (6), p.625-627

2015

Volltextzugriff (PDF)

Panic developments

Revista brasileira de psiquiatria, 2012-06, Vol.34 Suppl 1, p.S1-S04

Klein, Donald F

2012

Volltextzugriff (PDF)

DSM-IV Depression with Atypical Features: Is It Valid?

Neuropsychopharmacology (New York, N.Y.), 2009-12, Vol.34 (13), p.2625-2632

2009

Volltextzugriff (PDF)

Resolved : Mania is mistaken for ADHD in prepubertal children

Journal of the American Academy of Child and Adolescent Psychiatry, 1998-10, Vol.37 (10), p.1091-1099

BIEDERMAN, J

1998

Volltextzugriff (PDF)

Baseline Matters: The Importance of Covariation for Baseline Severity in the Analysis of Clinical Trials

The American journal of drug and alcohol abuse, 2011-09, Vol.37 (5), p.446-452

2011

Volltextzugriff (PDF)

Central nervous system drug development, basic, and clinical research: thinking outside the box

Journal of clinical psychopharmacology, 2011-10, Vol.31 (5), p.553-554

2011

Volltextzugriff (PDF)

Early Development of Monoamine Oxidase Inhibitors

Psychiatric annals, 2014-12, Vol.44 (12), p.563-566

2014

Volltextzugriff (PDF)

FDA post-marketing safety decisions

The journal of clinical psychiatry, 2006-08, Vol.67 (8), p.1305

Klein, Donald F

2006

Volltextzugriff (PDF)

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

The American journal of psychiatry, 2000-08, Vol.157 (8), p.1204-1211

Klein, Donald F.

2000

Volltextzugriff (PDF)

Conflict of Interest, Journal Review, and Publication Policy

Neuropsychopharmacology (New York, N.Y.), 2008-12, Vol.33 (13), p.3023-3026

2008

Volltextzugriff (PDF)

Panic developments

Revista brasileira de psiquiatria, 2012-06, Vol.34 Suppl 1 (suppl 1), p.S1-S2

Klein, Donald F

2012

Volltextzugriff (PDF)

Commentary by a clinical scientist in psychopharmacological research

Journal of child and adolescent psychopharmacology, 2007-06, Vol.17 (3), p.284-287

Klein, Donald F

2007

Volltextzugriff (PDF)

Validity of Clinical Trials of Antidepressants

The American journal of psychiatry, 2000-03, Vol.157 (3), p.327-337

2000

Volltextzugriff (PDF)

1 – 25 von 504

Menü

Weitere Dienste

Einstellungen

Issues for DSM-5: Whither Melancholia? The Case for Its Classification as a Distinct Mood Disorder

Whither Research Domain Criteria (RDoC)?: The Good, the Bad, and the Ugly

Lifelong opioidergic vulnerability through early life separation: A recent extension of the false suffocation alarm theory of panic disorder

Difficulties in panic studies

Paul Wender

Industry withdrawal from psychiatric medication development

The loss of serendipity in psychopharmacology

Panic, suffocation false alarms, separation anxiety and endogenous opioids

Improving detection of adverse effects of marketed drugs

The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children

Monoamine Oxidase Inhibitors: A Clinical Colloquy

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision

Intensive Design to Reinvigorate Psychiatric Drug Development

Panic developments

DSM-IV Depression with Atypical Features: Is It Valid?

Resolved : Mania is mistaken for ADHD in prepubertal children

Baseline Matters: The Importance of Covariation for Baseline Severity in the Analysis of Clinical Trials

Central nervous system drug development, basic, and clinical research: thinking outside the box

Early Development of Monoamine Oxidase Inhibitors

FDA post-marketing safety decisions

Flawed Meta-Analyses Comparing Psychotherapy With Pharmacotherapy

Conflict of Interest, Journal Review, and Publication Policy

Panic developments

Commentary by a clinical scientist in psychopharmacological research

Validity of Clinical Trials of Antidepressants

Aktive Filter

Suchergebnisse filtern